Skip to main content

Advertisement

SpringerLink
Log in

Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma (BCC) has rarely been investigated. The author immunohistochemically examined the expression of these molecules in 66 consecutive cases of BCC. In non-tumorous skin, NCAM chromogranin A, synaptophysin, c-KIT and PDGFRA expression was seen in the basal cell of the epidermis. NCAM, c-KIT and PDGFRA expression was also seen in the sweat glands and outer cells of hair follicles, but chromogranin and synaptophysin expression was not identified in these structures. In BCC, NCAM expression was seen in 95 % (63/66 cases). Its expression was membranous. Chromogranin A expression was recognized in 27 % (18/66 cases). Its expression was cytoplasmic. Synaptophysin expression was seen in 18 % (12/66 cases). Its expression was membranous and cytoplasmic. c-KIT expression was noted in 93 % (61/66 cases). Its expression was membranous and focally cytoplasmic. PDGFRA expression was seen in 65 % (43/66 cases). Its expression was membranous and cytoplasmic. The expression of these molecules in normal non-tumorous skin is a new finding. The expression of c-KIT and PDGFRA in BCC is also a new finding. In conclusion, the author described the normal (non-neoplastic) distribution of NCAM, chromogranin A, synaptophysin, c-KIT and PDGFRA. In addition, the author showed that, in cutaneous BCC, the expression of NCAM and c-KIT was high (95 and 93 % respectively), PDGFRA was intermediate (65 %), and chromogranin A and synaptophysin was relatively low (27 and 18 %, respectively).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kossard S, Epstein Jr EH, Cerio R, Yu LL, Weedon D. Basal cell carcinoma. In: LeBoit PE, Burg G, Weedon D, Sarasin A, editors. World health organization classification of tumours. Pathology and genetics of skin tumours. Lyon: IARC Press; 2006. p. 13–19.

  2. Dardi LE, Memoli VA, Gould VE. Neuroendocrine differentiation in basal cell carcinoma. J Cutan Pathol. 1981;8:335–41.

    Article  PubMed  CAS  Google Scholar 

  3. Visser R, Bosman FT. Neuroendocrine differentiation in basal cell carcinoma: a retrospective immunohistochemical and ultrastructural study. J Cutan Pathol. 1985;12:117–24.

    Article  PubMed  CAS  Google Scholar 

  4. George E, Swanson PE, Wick MR. Neuroendocrine differentiation in basal cell carcinoma: an immunohistochemical study. Am J Dermatopathol. 1989;11:131–5.

    Article  PubMed  CAS  Google Scholar 

  5. Ishida M, Kurashima R, Okabe H. Aberrant expression of class III beta-tubulin in basal cell carcinoma of the skin. Oncol Rep. 2009;22:733–7.

    PubMed  Google Scholar 

  6. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissue, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205–20.

    Article  PubMed  CAS  Google Scholar 

  7. Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.

    Article  PubMed  Google Scholar 

  8. Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.

    Article  PubMed  Google Scholar 

  9. Beljaards RC, Kirtschig G, Boorsma DM. Expression of neural cell adhesion molecule (CD56) in basal and squamous cell carcinoma. Dermatol Surg. 2008;34:1577–79.

    Google Scholar 

  10. Tsuura Y, Hiraki H, Watanabe K, Igarashi S, Shimamura K, Fukuda T, Suzuki T, Seito T. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed and paraffin-embedded tissues. Virchows Arch. 1994;424:135–41.

    Article  PubMed  CAS  Google Scholar 

  11. Blumming P, Nilsson O, Ahlman H, Welbencer A, Andersson MK, Sjolund K, Nilsson B. Gastrointestinal strumal tumor regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype. Endocr Relat Cancer. 2007;14:853–63.

    Article  Google Scholar 

  12. Xie J, Aszterbaum M, Zhang X, Bonifas JM, Zachary C, Epstein E, McCormick F. A role of PGDFRα in basal cell carcinoma proliferation. Proc Natl Acad Sci USA. 2001;98:9255–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The author declares no conflict of interest.

Author information

Authors and Affiliations

  1. Departments of Pathology, Shizuoka City Shimizu Hospital, Miyakami 1231, Shimizu-Ku, Shizuoka, 424-8636, Japan

    Tadashi Terada

Authors
  1. Tadashi Terada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadashi Terada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terada, T. Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases. Med Oncol 30, 444 (2013). https://doi.org/10.1007/s12032-012-0444-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-012-0444-0

Keywords

Search

Navigation